Chronic kidney disease and venous thromboembolism: a prospective study
Open Access
- 29 March 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 25 (10), 3296-3301
- https://doi.org/10.1093/ndt/gfq179
Abstract
Background. The incidence of venous thromboembolism (VTE) is increased with severe kidney disease, but whether less-severe chronic kidney disease (CKD) increases the risk of VTE is less certain. Methods. We studied this in a prospective cohort of 10 700 whites and African Americans, aged 53–75 years, attending Visit 4 (1996–98) of the Atherosclerosis Risk in Communities Study. Estimated glomerular filtration rate (eGFR) values were estimated from prediction equations based on serum creatinine (eGFRcreat) or cystatin C (eGFRcys). Normal kidney function was defined as eGFR ≥90 ml/min/1.73 m2, mildly decreased kidney function as eGFR between 60 and 89 ml/min/1.73 m2 and Stage 3 to 4 CKD as eGFR between 15 and 59 ml/min/1.73 m2. VTE occurrence (n = 228) was ascertained over a median of 8.3 years. Results. For eGFRcys, the age-, race- and sex-adjusted hazard ratios of total VTE were 1.0, 1.40 and 1.94 (P trend = 0.003) for normal kidney function, mildly impaired kidney function and Stage 3 to 4 CKD, respectively. These respective hazard ratios were moderately attenuated to 1.0, 1.26 and 1.60 (P trend = 0.04) with adjustment for hormone replacement therapy, diabetes and body mass index. Associations between CKD based on eGFRcys and VTE were slightly stronger for idiopathic VTE than for secondary VTE. In contrast, CKD based on eGFRcreat was not associated with total VTE occurrence. Conclusions. Stage 3 to 4 CKD, based on eGFRcys but not eGFRcreat, was associated with an approximately 1.6-fold increased risk of VTE.This publication has 25 references indexed in Scilit:
- Method of Glomerular Filtration Rate Estimation Affects Prediction of Mortality RiskJournal of the American Society of Nephrology, 2009
- Chronic kidney disease and venous thromboembolism: epidemiology and mechanismsCurrent Opinion in Pulmonary Medicine, 2009
- Differential Estimation of CKD Using Creatinine- Versus Cystatin C–Based Estimating Equations by Category of Body Mass IndexAmerican Journal of Kidney Diseases, 2009
- Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Kidney Diseases, 2009
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Activated Partial Thromboplastin Time and Risk of Future Venous ThromboembolismThe American Journal of Medicine, 2008
- High Absolute Risks and Predictors of Venous and Arterial Thromboembolic Events in Patients With Nephrotic SyndromeCirculation, 2008
- Chronic Kidney Disease Increases Risk for Venous ThromboembolismJournal of the American Society of Nephrology, 2008
- Cystatin C: Efficacy as Screening Test for Reduced Glomerular Filtration RateAmerican Journal of Nephrology, 2000
- Prevalence of Acute Pulmonary Embolism Among Patients in a General Hospital and at AutopsySocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995